×
Valneva SE Total Liabilities 2021-2024 | VALN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Valneva SE total liabilities from 2021 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Valneva SE Total Liabilities 2021-2024 | VALN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Valneva SE total liabilities from 2021 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$205.5B
Stryker (SYK)
$138.7B
Boston Scientific (BSX)
$121.5B
Medtronic (MDT)
$113.7B
EssilorLuxottica (ESLOY)
$104.2B
Haleon (HLN)
$48.6B
Lonza Group Ag (LZAGY)
$45.9B
ResMed (RMD)
$36.9B
Koninklijke Philips (PHG)
$29.3B
Terumo (TRUMY)
$27.8B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$20.3B
Insulet (PODD)
$16.5B
Smith & Nephew SNATS (SNN)
$13.5B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$9.2B
BellRing Brands (BRBR)
$7.7B
Lantheus Holdings (LNTH)
$7.3B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$3.9B
TG Therapeutics (TGTX)
$3.9B
GN Store Nord (GNNDY)
$3.8B
Perrigo (PRGO)
$3.8B
Neogen (NEOG)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Envista Holdings (NVST)
$3.3B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Maravai LifeSciences Holdings (MRVI)
$2.3B
Green Thumb Industries (GTBIF)
$2.2B